Covalon Licenses Intellectual Property from the University of Michigan


MISSISSAUGA, Ontario – Covalon Technologies Ltd., an advanced medical technologies company, has announced in a press release a licensing agreement with the University of Michigan’s Center for Integrative Research in Critical Care (“MCIRCC”), whereby Covalon has licensed intellectual property from MCIRCC that, when commercialized, could prevent or reduce the occurrence of Ventilator-Associated Pneumonia (“VAP”), a potentially devastating hospital acquired infection, and the most common nosocomial infection in critically ill patients.


Subscribe to get the latest news